Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Addison’s Disease Market’s Growth Trajectory From 2025 To 2034?
In the past few years, the market for Addison’s disease has seen robust growth. The market is projected to increase from $2.05 billion in 2024 to $2.24 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. This substantial growth during the historic period can be linked to numerous factors, including a global rise in Addison’s disease cases, increased knowledge about adrenal insufficiency, an uptick in spending on healthcare, a surge in the occurrence of autoimmune diseases, and a growing elderly population.
Expectations are high for a significant expansion in the market size for Addison’s disease in the coming years, with projections indicating a growth to$3.24 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The anticipated market growth during this forecast period is linked to the escalating demand for improved therapeutics, an increased emphasis on initial diagnosis, a surge in the number of congenital adrenal hyperplasia cases, the evolution of telemedicine services, and an uptick in occurrences of adrenal tuberculosis. The forecast period will likely also witness significant trends such as enhancements in laboratory testing processes, progress in hormone replacement therapies, breakthroughs in imaging technologies, the debut of long-lasting injectable formulations, and the inclusion of artificial intelligence in diagnostic methods.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21084&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Addison’s Disease Market?
The rise in the occurrence of autoimmune diseases is anticipated to fuel the expansion of the Addison’s disease market. Autoimmune diseases, which result when the immune system inappropriately assails the body’s healthy tissues, causing swelling and harm, are on the rise. The increasing occurrence of autoimmune diseases is influenced by genetic susceptibilities, environmental aspects such as pollutants and changes in diet, and lifestyle factors such as stress and insufficient physical activity. With the escalating prevalence of autoimmune diseases, the likelihood of them coinciding with Addison’s disease is on the rise, given that many patients acquire additional autoimmune disorders. For instance, a survey by Versorgungsatlas.de, a German organization, in November 2024 showed that out of 73,241,305 ensured individuals in 2022, 6,304,340 were diagnosed with at least one autoimmune disease. This led to a raw prevalence rate of 8.61%, which surpassed previous estimates of between 3% and 9%. As such, the escalating occurrence of autoimmune diseases is propelling the expansion of the Addison’s disease market.
Which Key Market Segments Comprise the Addison’s Disease Market and Drive Its Revenue Growth?
The addison’s diseasemarket covered in this report is segmented –
1) By Type: Primary Adrenal Insufficiency; Secondary Adrenal Insufficiency; Tertiary Adrenal Insufficiency
2) By Drug Class: Oral Corticosteroid; Hydrocortisone; Fludrocortisone; Corticosteroid Injections
3) By Diagnosis: Laboratory Testing; Imaging Testing
4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Primary Adrenal Insufficiency: Autoimmune Addison’s Disease; Infectious Addison’s Disease; Other causes of primary adrenal insufficiency
2) By Secondary Adrenal Insufficiency: Pituitary gland dysfunction; Hypothalamic dysfunction
3) By Tertiary Adrenal Insufficiency: Hypothalamic or pituitary suppression due to long-term steroid use; Other causes of tertiary adrenal insufficiency
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21084&type=smp
Which Areas Are Leading Regions in the Addison’s Disease Market Expansion Across the Globe?
North America was the largest region in the addison’s disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the addison’s disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theAddison’s Disease Market Over the Coming Years?
Leading businesses in the Addison’s disease marketplace are directing their current efforts towards innovative solutions like regenerative therapy in the hopes of expanding treatment alternatives, ameliorating patient outcomes and possibly eliminating the everlasting dependency on hormone replacement therapies by exciting the body’s inherent adrenal function. Medical treatments aimed at replacing or rejuvenating human cells, tissue, or organs to resume typical functioning and promote healing from injuries, diseases, or degeneration are commonly referred to as regenerative therapies. As an example, Eton Pharmaceuticals, Inc., a renowned American pharmaceutical company known for its emphasis on creating and commercialising groundbreaking treatments for infrequent diseases, received the FDA’s approval of their New Drug Application (NDA) for ET-400, their own unique hydrocortisone oral solution formula in July 2024. ET-400, in contrast to other formulas that may necessitate refrigeration, can be easily stored and transported. Its liquid form can cater to the specific needs of young patients who might find it challenging to swallow conventional tablets, also offering the added benefit of precise dosing.
View the full report here:
https://www.thebusinessresearchcompany.com/report/addisons-disease-global-market-report
How Is the Addison’s Disease Market Conceptually Defined?
Addison’s disease is a rare disorder where the adrenal glands produce insufficient amounts of cortisol and aldosterone due to damage, caused by an autoimmune response. Symptoms include fatigue, muscle weakness, weight loss, low mood, and skin changes. Lifelong hormone replacement therapy is required to manage the condition and prevent severe complications such as adrenal crisis.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21084
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model